views
Stocks To Watch: On Monday, the 30-share BSE Sensex surged by 2,507.47 points, or 3.39%, to reach a new closing high of 76,468.78 points, with 25 constituents in the green and five in the red. During the day, the index spiked 2,777.58 points, or 3.75%, to hit a record intraday peak of 76,738.89.
Lok Sabha Election Results: Sensex, Nifty Live Updates
Similarly, the NSE Nifty gained 733.20 points, or 3.25%, to close at 23,263.90. It also soared 808 points, or 3.58%, during the day to achieve a fresh intraday all-time high of 23,338.70.
Here’s a slew of stocks that will be in focus on June 04 for various reasons;
Dr Reddy’s Laboratories: The company’s subsidiary, Aurigene Pharmaceutical Services, a global CRDMO, has inaugurated its biologics facility in Hyderabad, providing process development and clinical scale manufacturing capabilities.
Welspun Corp: The company announced that its associate entity, EPIC, has secured multiple agreements with Saudi Arabian Oil Co. (Aramco) valued at SAR 1.65 billion (approximately Rs 3,670 crore) for the supply of steel pipes.
Mahindra & Mahindra Financial Services:In May, its total disbursement reached Rs 4,430 crore, marking a 7% increase compared to the same month last year. Business assets, amounting to around Rs 1,05,250 crore, saw a year-on-year growth of 23% in May.
Zee Entertainment: The company announced that a board of directors meeting is slated for June 6 to deliberate on raising funds through the issuance of equity shares and/or other permissible securities.
Wipro: The technology services and consulting firm has named Bruno Schenk as the Country Head and Managing Director for Switzerland, with immediate effect.
Bharat Forge: The Australian Securities and Investments Commission (ASIC) has approved the deregistration of Kalyani Strategic Systems Australia Pty (KSSL Australia).
Kalyan Jewellers: The company has purchased the remaining 15% stake in its e-commerce subsidiary Enovate Lifestyles from Rupesh Jain, the operator behind the Candere brand, for Rs 42 crore.
Comments
0 comment